Chemotherapy: Adjuvant chemotherapy in older patients with breast cancer

2009-10-14

Nature Reviews Clinical Oncology , Volume 6 - Issue 10 p. 563- 565

Additional Metadata
Keywords	adjuvant therapy, age, aged, antineoplastic agent, article, blood toxicity, breast cancer, cancer adjuvant therapy, cancer combination chemotherapy, cancer relapse, cancer survival, capecitabine, clinical trial, cyclophosphamide, doxorubicin, drug clearance, drug distribution, drug dose reduction, drug efficacy, drug fatality, drug tolerability, drug withdrawal, febrile neutropenia, fluorouracil, human, methotrexate, overall survival, patient compliance, priority journal, tamoxifen
Persistent URL	doi.org/10.1038/nrclinonc.2009.142, hdl.handle.net/1765/17796
Journal	Nature Reviews Clinical Oncology
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Jager, A., Verweij, J., & Sleijfer, S. (2009). Chemotherapy: Adjuvant chemotherapy in older patients with breast cancer. Nature Reviews Clinical Oncology, 6(10), 563–565. doi:10.1038/nrclinonc.2009.142

Publication